Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 2, Issue : 3, Year : 2016
Article Page : 242-247
Abstract
Background: Changes in the organ of sight in rheumatic diseases may result from the inflammatory process because of immune-mediated ocular inflammation which causes severe debilitation and visual loss. Therefore by understanding the various ocular presentations of these systemic inflammatory diseases is vital so as to arrive expeditiously at the correct diagnosis and treatment plan with the goal of preserving visual function.
Methods: A cross sectional study was done on patients over a period from November 2014 to September 2015. A total of 102 patients with rheumatic disease were investigated for any ocular manifestations after obtaining informed written consent. ACR(American College of Rheumatology) criteria was used for the diagnosis of Rheumatic Diseases. Ocular investigation for dry eye included Schirmer’s test, Tear film break up time test (TBUT) and 1% Rose Bengal test. Positivity for Immunological factors and their association to ocular manifestations statistically analyzed.
Results: The overall incidence of ocular manifestations of the rheumatic disease process in the study was 63.7% (65 cases). Uveitis incidence was 34.3%(35 cases) being the commonest ocular abnormality detected followed by KCS of 19.6%(20cases). The total number of cases with ANA positivity in Rheumatic disease is 22 as in Table 4, those with ocular manifestations and ANA positivity is 16 out of 20 (80%) as in Table 5. Six (50%) of the twelve patients with Keratoconjunctivitis sicca had high Rheumatoid factor titer values by slide agglutination (> 1:128). Conversely of the seven patients with high Rheumatoid factor titer values (> 1:128), six (85.7%) had Keratoconjunctivitis sicca.
Conclusion: Therefore, following a multidisciplinary approach by ophthalmologists, rheumatologists, physicians and pediatrician would help for an early intervention to preserve vision where possible.
Keywords: Anti-Nuclear Antibody (ANA), Keratoconjunctivitis sicca, Ocular Manifestations, Rheumatic Diseases, Rheumatoid Factor (RF), Uveitis
How to cite : Hassan K M, Manish S, Ravikumar R, Hussain S A, Ocular manifestations of rheumatic diseases: A hospital based study. Indian J Clin Exp Ophthalmol 2016;2(3):242-247
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
